142 related articles for article (PubMed ID: 37202155)
1. Association between the use of statins and risk of interstitial lung disease/idiopathic pulmonary fibrosis: time-dependent analysis of population-based nationwide data.
Jang HJ; Lee DY; Loloci G; Jeong J; Choi WI
Eur Respir J; 2023 Jul; 62(1):. PubMed ID: 37202155
[TBL] [Abstract][Full Text] [Related]
2. Incidence of idiopathic pulmonary fibrosis in Korea based on the 2011 ATS/ERS/JRS/ALAT statement.
Gjonbrataj J; Choi WI; Bahn YE; Rho BH; Lee JJ; Lee CW
Int J Tuberc Lung Dis; 2015 Jun; 19(6):742-6. PubMed ID: 25946370
[TBL] [Abstract][Full Text] [Related]
3. Nationwide epidemiologic study for fibrosing interstitial lung disease (F-ILD) in South Korea: a population-based study.
Joung KI; Park H; Park S; Shin JY; Kim YH
BMC Pulm Med; 2023 Mar; 23(1):98. PubMed ID: 36949407
[TBL] [Abstract][Full Text] [Related]
4. Association between statin use and the risk for idiopathic pulmonary fibrosis and its prognosis: a nationwide, population-based study.
Park J; Lee CH; Han K; Choi SM
Sci Rep; 2024 Apr; 14(1):7805. PubMed ID: 38565856
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent propensity-matched general population study of the effects of statin use on cancer risk in an interstitial lung disease and pulmonary fibrosis cohort.
Yeh JJ; Lai JN; Lin CL; Hsu CY; Kao CH
BMJ Open; 2021 Oct; 11(10):e047039. PubMed ID: 34635513
[TBL] [Abstract][Full Text] [Related]
6. The preventative effects of statin on lung cancer development in patients with idiopathic pulmonary fibrosis using the National Health Insurance Service Database in Korea.
Lee YJ; Kang N; Nam J; Lee EG; Ryoo J; Kwon SS; Kim YH; Kang HS
PLoS One; 2024; 19(3):e0299484. PubMed ID: 38478558
[TBL] [Abstract][Full Text] [Related]
7. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
8. Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease.
Cutting CC; Bowman WS; Dao N; Pugashetti JV; Garcia CK; Oldham JM; Newton CA
Chest; 2021 May; 159(5):1913-1921. PubMed ID: 33484728
[TBL] [Abstract][Full Text] [Related]
9. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
10. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
Pan L; Liu Y; Sun R; Fan M; Shi G
Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
[TBL] [Abstract][Full Text] [Related]
11. Effects of statins and steroids on coronary artery disease and stroke in patients with interstitial lung disease and pulmonary fibrosis: A general population study.
Yeh JJ; Lin CL; Hsu NH; Kao CH
PLoS One; 2021; 16(10):e0259153. PubMed ID: 34705851
[TBL] [Abstract][Full Text] [Related]
12. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
13. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
[TBL] [Abstract][Full Text] [Related]
14. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
Mortimer KM; Bartels DB; Hartmann N; Capapey J; Yang J; Gately R; Enger C
Respiration; 2020; 99(2):108-118. PubMed ID: 31982886
[TBL] [Abstract][Full Text] [Related]
15. Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.
Singer D; Bengtson LGS; Conoscenti CS; Laouri M; Shetty SS; Anderson AJ; Brown KK
Ann Am Thorac Soc; 2022 Jul; 19(7):1112-1121. PubMed ID: 35015982
[No Abstract] [Full Text] [Related]
16. Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis.
Kou L; Kou P; Luo G; Wei S
Oxid Med Cell Longev; 2022; 2022():6197219. PubMed ID: 35345828
[TBL] [Abstract][Full Text] [Related]
17. Survival and outcomes after lung transplantation for connective tissue disease-associated interstitial lung diseases.
Yang X; Wei D; Liu M; Wu B; Zhang J; Xu H; Ye S; Liu F; Hu C; Chen J
Clin Rheumatol; 2021 Sep; 40(9):3789-3795. PubMed ID: 33755837
[TBL] [Abstract][Full Text] [Related]
18. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.
Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS
Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413
[TBL] [Abstract][Full Text] [Related]
19. Acute exacerbations of fibrotic interstitial lung diseases.
Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
[TBL] [Abstract][Full Text] [Related]
20. A cohort study of interstitial lung diseases in central Denmark.
Hyldgaard C; Hilberg O; Muller A; Bendstrup E
Respir Med; 2014 May; 108(5):793-9. PubMed ID: 24636811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
